Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Front-line”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableTemporarily Not AvailableNCT07319910
What this trial is testing

Continued Access Program for Tumor Treating Fields (TTFields) Used With Chemotherapy (Gemcitabine and Nab-Paclitaxel) in Adults With Locally Advanced Pancreatic Cancer (PANOVA-3CA)

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
NovoCure GmbH
Early research (Phase 1)Study completedNCT03245892
What this trial is testing

Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer

Who this might be right for
High Grade Serous OvarianFallopian TubePrimary Peritoneal Cancer
Memorial Sloan Kettering Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT01336933
What this trial is testing

Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaHepatosplenic T-cell Lymphoma+1 more
University of Nebraska 34
Not applicableStudy completedNCT07443098
What this trial is testing

Front Line Agreement in Diagnosis and Treatment for Musculoskeletal Dysfunctions

Who this might be right for
Musculoskeletal DiseasesLow Back PainEmergency Service, Hospital+4 more
Bern University of Applied Sciences 102
Testing effectiveness (Phase 2)Study completedNCT03455517
What this trial is testing

Activity and Safety of Front-line Venetoclax and Rituximab in Young and Fit Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 77
Testing effectiveness (Phase 2)Study completedNCT00965289
What this trial is testing

High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell Lymphoma

Who this might be right for
B-Cell Lymphoma
Nantes University Hospital 42
Testing effectiveness (Phase 2)Study completedNCT01994850
What this trial is testing

Brentuximab Vedotin and Chemotherapy in CD30+ PMBL, Diffuse Large B-Cell, and Grey Zone Lymphoma Patients

Who this might be right for
CD30 Positive Primary Mediastinal Large B-cell LymphomaCD30-Positive Diffuse Large B-Cell LymphomaCD30-Positive Gray Zone Lymphoma
Abramson Cancer Center at Penn Medicine 32
Not applicableStudy completedNCT03231189
What this trial is testing

Cardiac MRI in Front Line for the Diagnosis of Coronary Artery Disease as the Etiology of Left Ventricular Dysfunction

Who this might be right for
Ischemic Cardiomyopathy
Assistance Publique - Hôpitaux de Paris 415
Large-scale testing (Phase 3)Study completedNCT00676507
What this trial is testing

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Who this might be right for
Lung NeoplasmCarcinoma Non-small Cell Lung Cancer Stage IIIACarcinoma Non-small Cell Lung Cancer Stage IIIB+1 more
NovaRx Corporation 532
Testing effectiveness (Phase 2)Study completedNCT01932710
What this trial is testing

A Feasibility Study of Prophylactic White Blood Cell Transfusions

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 45
Testing effectiveness (Phase 2)Study completedNCT01641107
What this trial is testing

Phase II Front-line Ponatinib in Adult Philadelphia+/BCR-ABL+ Acute Lymphoblastic Leukemia.

Who this might be right for
Philadelphia PositiveBCR-ABL PositiveAcute Lymphoblastic Leukemia
Incyte Corporation 44
Large-scale testing (Phase 3)UnknownNCT02907385
What this trial is testing

Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing

Who this might be right for
Rectal CancerAnastomotic Leak
LifeBond Ltd. 736
Large-scale testing (Phase 3)Study completedNCT01239732
What this trial is testing

The Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Hoffmann-La Roche 1,021
Testing effectiveness (Phase 2)Active Not RecruitingNCT06164275
What this trial is testing

Pembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin Lymphoma

Who this might be right for
Classic Hodgkin Lymphoma
Northwestern University 30
Testing effectiveness (Phase 2)Study completedNCT01527422
What this trial is testing

Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab Pateinets With Aggresive NHL

Who this might be right for
LymphomaNon Hodgkin's Lymphoma
Fernando Cabanillas 60
Early research (Phase 1)Study completedNCT03742258
What this trial is testing

Combination Chemotherapy and TAK-659 as Front-Line Treatment in Treating Patients With High-Risk Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma Activated B-Cell TypeDiffuse Large B-Cell Lymphoma Germinal Center B-Cell Type+4 more
Northwestern University 12
Testing effectiveness (Phase 2)Study completedNCT01620190
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
University of Washington 26
Testing effectiveness (Phase 2)Study completedNCT02399137
What this trial is testing

MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Merrimack Pharmaceuticals 88
Testing effectiveness (Phase 2)Study completedNCT01716806
What this trial is testing

Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Hodgkin DiseasePeripheral T Cell Lymphoma
Seagen Inc. 131
Large-scale testing (Phase 3)Study completedNCT02099747
What this trial is testing

HATG+CsA vs hATG+CsA+Eltrombopag for SAA

Who this might be right for
Severe Aplastic Anemia
European Society for Blood and Marrow Transplantation 202
Next Page